| 英文名称 |
中文名称 |
CAS |
|
2-carboxy-5-methylpyrazine 1,4-dioxide
|
阿昔莫司杂质1 |
2734844-49-4 |
|
Xanomeline Impurity 1
|
呫若美林杂质1 |
174656-58-7 |
|
2-carboxy-5-methylpyrazine 1-oxide
|
阿昔莫司杂质5 |
98502-96-6 |
|
Ural licorice saponin B
|
乌拉尔甘草皂苷B |
|
|
Vigabatrin Impurity 8
|
氨己烯酸杂质8 |
7529-16-0 |
|
Betahistine Impurity 4
|
倍他司汀杂质4 |
101252-40-8 |
|
Methyl 5-chloropentanoate
|
5-氯戊酸甲酯 |
14273-86-0 |
|
Ethenesulfonic acid methyl ester
|
乙烯基磺甲酯 |
1562-31-8 |
|
Left western impurity S-isomer
|
左西杂质S-异构体 |
163837-48-7 |
|
Vancomycin Impurity L
|
万古霉素杂质L |
79517-31-0 |
|
Bis(4-sulfobutyl)ether Disodium Salt
|
双-(4-磺丁基)醚二钠盐 |
183278-30-0 |
|
Cefazolin Impurity I
|
头孢唑林杂质I |
1172998-53-6 |
|
Samidorphan
|
|
852626-89-2 |
|
(S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline
|
替那帕诺中间体 |
1870821-29-6 |
|
2-((5-bromopyrimidin-2-yl)oxy)ethan-1-ol
|
2-[(5-溴-2-嘧啶基)氧基]乙醇 |
1246922-88-2 |
|
Betahistine Impurity 3
|
倍他司汀杂质3 |
19690-13-2 |
|
Lercanidipine Hydrochloridereference substance (crystal form I)
|
盐酸乐卡地平对照品(I晶型) |
132866-11-6 |
|
Tyloxapol
|
泰洛沙泊 |
25301-02-4 |
|
(+)-Corey Lactone Diol
|
(+)-科立内酯二醇 |
76704-05-7 |
|
Bevantolol Impurity 16
|
贝凡洛尔杂质16 |
14569-61-0 |
|
Faropenem finished product impurity 23
|
法罗培南成品杂质23 |
2357-76-8 |
|
Betahistine Impurity 2
|
倍他司汀杂质2 |
32635-81-7 |
|
Bevantolol Impurity 07
|
贝凡洛尔杂质07 |
63434-21-9 |
|
Vancomycin Impurity A
|
万古霉素杂质A |
91700-98-0 |
|
Vancomycin Impurity H
|
万古霉素杂质H |
357396-41-9 |
|
Bilastine Impurity 05
|
比拉斯汀杂质05 |
2767508-98-3 |
|
4-hydroxybutane-1-sulfonic acid
|
4-羟基丁烷-1-磺胺 |
26978-64-3 |
|
Cefoperam (USP Impurity A)
|
头孢托仑(USP杂质A) |
|
|
Betahistine Impurity 10
|
倍他司汀杂质10 |
54765-14-9 |
|
N - [5- (4-bromophenyl) -6- [2- [(5-bromo-2-pyrimidinyl) oxy] ethoxy] -4-pyrimidinyl] aminosulfonamide
|
N-[5-(4-溴苯基)-6-[2-[(5-溴-2-嘧啶基)氧基]乙氧基]-4-嘧啶基]氨基磺酰胺 |
110-65-7 |
|
Vigabatrin Impurity 1
|
氨己烯酸杂质1 |
60643-86-9 |
|
Celecoxib Impurity 52
|
塞来昔布杂质52 |
1803258-57-2 |
|
Eicosanol
|
二十醇 |
629-96-9 |
|
Betahistine Impurity 9
|
倍他司汀杂质9 |
128225-22-9 |
|
Ornidazole Impurity 17
|
奥硝唑杂质17 |
95881-05-3 |
|
Lorazepam USP Impurity A
|
劳拉西泮USP杂质A |
2848-96-6 |
|
5-Methylpyrazine-2-carbonitrile
|
阿昔莫司杂质8 |
98006-91-8 |
|
Xanomeline Impurity 3
|
呫若美林杂质3 |
174656-57-6 |
|
2-Pyrazinecarboxamide, 6-methyl-, 4-oxide
|
阿昔莫司杂质11 |
51037-27-5 |
|
(3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-yl acetate
|
3,4-二氟-2-甲氧基苯基-4,5-二甲基-5-三氟甲基四氢呋喃-2-基乙酸酯 |
2875066-46-7 |
|
NEU1131-H reference standard
|
NEU1131-H对照品 |
1644251-59-1 |
|
Acetyl byproduct 2
N - (4-chloro-2-sulfamoylphenyl) acetamide
|
乙酰副产物 2
N-(4-氯-2-氨磺酰基苯基)乙酰胺 |
19185-77-4 |
|
Nicotine Nitrogen Oxide TRC
|
尼古丁氮氧化物TRC |
|
|
methyl 5-methylpyrazine-2-carboxylate
|
阿昔莫司杂质15 |
41110-32-2 |
|
1-Oxylato-3-carboxypyrazine-1-ium
|
阿昔莫司杂质21 |
874-54-4 |
|
Vancomycin Impurity C
|
万古霉素杂质C |
82198-76-3 |
|
Tadalafil iMpurity 16
|
他达拉非杂质16 |
951661-82-8 |
|
Macitentan Impurity
|
马西替坦杂质 |
1433875-21-8 |
|
Macitentan Impurity K
|
马西坦坦杂质K |
2211054-90-7 |
|
Bilastine Impurity 01
|
比拉斯汀杂质01 |
1841081-72-8 |
|
(-)-Corey Lactone Diol
|
(-)-科立内酯二醇 |
32233-40-2 |
|
4-Ethylaniline
|
对乙苯胺 |
589-16-2 |
|
Betahistine Impurity 5
|
倍他司汀杂质5 |
49745-42-8 |
|
Xanomeline Impurity 13
|
呫若美林杂质13 |
131987-69-4 |
|
Faropenem finished product impurity 22
|
法罗培南成品杂质22 |
87024-25-7 |
|
Vigabatrin Impurity 10
|
氨己烯酸杂质10 |
71107-20-5 |
|
Vigabatrin Impurity 7
|
氨己烯酸杂质7 |
27428-45-1 |
|
5-Methylpyrazine-2,3-dicarboxamide
|
阿昔莫司杂质10 |
74290-70-3 |
|
Vancomycin Impurity F
|
万古霉素杂质F |
2415254-43-0 |
|
Benazepril Hydrochloride EDQM System Applicability Reference Standard
|
盐酸贝那普利EDQM系统适用性对照品 |
86541-74-4 |
|
Methyl 4-[[[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]-2-pyridinecarboxylate
|
4-(2R,3S,4S,5R)-3-(3,4-二氟-2-甲氧基苯基)-4,5-二甲基-5-三氟甲基四氢呋喃-2-甲酰胺基吡啶甲酸甲酯 |
2879218-02-5 |
|
Pyridinium, 5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-3-hydroxy-1-methyl-
|
呫若美林杂质7 |
2414049-88-8 |
|
Intermediate impurity
|
中间体杂质 |
2875066-56-9 |
|
2(5H)-Furanone
|
2(5H)-呋喃酮 |
497-23-4 |
|
Vorapaxar
|
沃拉帕沙中间体3 |
900161-12-8 |
|
Vigabatrin EP Impurity E
|
氨己烯酸EP杂质E |
1378466-25-1 |
|
Vigabatrin Impurity 15
|
氨己烯酸杂质15 |
68506-86-5 |
|
2-Pyrazinecarboxylic acid, 6-methyl-, 4-oxide
|
阿昔莫司杂质3 |
51037-31-1 |
|
Bevantolol Impurity 10
|
贝凡洛尔杂质10 |
54737-83-6 |
|
2-METHYL-1H-IMIDAZOLE-4,5-DICARBONITRILE
|
阿昔莫司杂质6 |
40056-53-9 |
|
N-((Z)-2-amino-1,2-dicyanoethenyl)acetamide
|
阿昔莫司杂质7 |
65604-69-5 |
|
Betahistine Impurity 11
|
倍他司汀杂质11 |
91029-17-3 |
|
2-methylpyrazine 1-oxide
|
阿昔莫司杂质17 |
31396-35-7 |
|
(+/-)-Corey Lactone Diol
|
(+/-)-科立内酯二醇 |
54423-47-1 |
|
d-Cloprostenol Sodium
|
D-氯前列醇钠 |
62561-03-9 |
|
Vigabatrin Impurity 9
|
氨己烯酸杂质9 |
2324151-81-5 |
|
Vigabatrin Impurity 12
|
氨己烯酸杂质12 |
1824506-31-1 |
|
Vigabatrin Impurity 3
|
氨己烯酸杂质3 |
2512190-67-7 |
|
Betahistine Impurity 6
|
倍他司汀杂质6 |
37445-98-0 |
|
Bilastine Impurity 01
|
比拉斯汀杂质01 |
110963-63-8 |
|
Bilastine Impurity 02
|
比拉斯汀杂质02 |
1181267-36-6 |
|
Betahistine Impurity 8
|
倍他司汀杂质8 |
103-74-2 |
|
5-(methoxycarbonyl)-2-methylpyrazine 1-oxide
|
阿昔莫司杂质18 |
74416-38-9 |
|
3-amino-2,3-dihydroindene-1-one
|
3-氨基茚满-1-酮 |
117291-44-8 |
|
Bevantolol Impurity 05
|
贝凡洛尔杂质05 |
54738-06-6 |
|
Vigabatrin Impurity 13
|
氨己烯酸杂质13 |
21358-47-5 |
|
5-Methyl-2-pyrazinecarboxylic acid
|
阿昔莫司杂质4 |
5521-55-1 |
|
5-Methyl-2,3-pyrazinedicarboxylic acid
|
阿昔莫司杂质16 |
5521-60-8 |
|
6-Methylpyrazine-2-carboxamide
|
阿昔莫司杂质9 |
5521-62-0 |
|
Betahistine Impurity 27
|
倍他司汀杂质27 |
55967-94-7 |
|
Pyrazine, 2-methyl-,1,4-dioxide
|
阿昔莫司杂质2 |
32046-26-7 |
|
D-Cloprostenol
|
D-氯前列醇 |
54276-21-0 |
|
6-methylpyrazine-2-carboxylic acid
|
阿昔莫司杂质12 |
5521-61-9 |
|
Beta-methylpyridine-2-ethanol
|
beta-亚甲基吡啶-2-乙醇 |
58379-60-5 |
|
Alarelin
|
阿拉瑞林 |
79561-22-1 |
|
5-(ethoxycarbonyl)-2-methylpyrazine 1-oxide
|
阿昔莫司杂质22 |
51037-35-5 |
|
Bevantolol Impurity 01
|
贝凡洛尔杂质01 |
2186-24-5 |
|
Bevantolol Impurity 02
|
贝凡洛尔杂质02 |
621-24-9 |
|
Bilastine Impurity 03
|
比拉斯汀杂质03 |
202189-76-2 |
|
Bevantolol Impurity 03
|
贝凡洛尔杂质03 |
42865-04-3 |